Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,847 | -6,255 | -630 | -4,400 | -3,000 |
| Depreciation Amortization | 616 | 1,152 | 170 | 710 | 520 |
| Accounts payable and accrued liabilities | 446 | N/A | N/A | N/A | N/A |
| Other Working Capital | 686 | 947 | -50 | 390 | 290 |
| Other Operating Activity | -329 | 363 | -10 | 650 | 50 |
| Operating Cash Flow | $-428 | $-3,793 | $-520 | $-2,650 | $-2,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -1 | -270 | -250 |
| Other Investing Activity | 1 | 231 | 0 | 2,530 | 1,790 |
| Investing Cash Flow | $1 | $231 | $-1 | $2,260 | $1,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 775 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -164 | 3,652 | 440 | 440 | -390 |
| Financing Cash Flow | $611 | $3,652 | $440 | $440 | $-390 |
| Beginning Cash Position | 172 | 81 | 1,330 | 1,280 | 1,280 |
| End Cash Position | 355 | 172 | 1,250 | 1,330 | 290 |
| Net Cash Flow | $184 | $91 | $-70 | $40 | $-980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -428 | -3,793 | -520 | -2,650 | -2,140 |
| Free Cash Flow | -428 | -3,793 | -520 | -2,650 | -2,140 |